SlideShare a Scribd company logo
Is there any evidence that ‘NIHR HLO1’ has had a
counterproductive impact upon the intrinsic quality of
research being delivered through the NHS in England
between 2008 & 2016?
Discussion Session – Theme 3 ‘Working Better Together’
Today’s Session
1. Background
2. What prompted the question?
3. What does the data look like?
4. Delivering quality & quantity
5. Working better together
6. What’s been left unsaid
NIHR Clinical Research Network
• [1] Set up in 2006 to “Improve health and wealth of nation”
• 15 LCRNs, Central Coordinating Centre
• All NHS Trusts research active
• ~650,000 participants, ~4,500 studies p.a.
• UK more attractive to Sponsors
• Retained & increased commercial research activity
• Research training (~100,000 GCP)
• Fund a large workforce (~40,000 staff)
• [2] Economic and health benefits (KPMG LLG, 2016)
Key to success, several key performance indicators [3]…
Increase the number of
participants recruited
into NIHR CRN
Portfolio studies
Increase the proportion
of studies in the NIHR
CRN Portfolio delivering
to recruitment
target to time
Increase the number of
commercial contract
studies delivered
through the NIHR CRN
Reduce the time taken
for eligible studies to
achieve set-up in the
NHS
Reduce the time taken to
recruit to recruit first
participant into NIHR
Portfolio studies
Increase NHS
participation in NIHR
CRN Portfolio studies
Increase the number of
participants recruited
into Dementia and
Neurodegeneration
studies on the Portfolio
NIHR CRN – Founding Aims
“More patients and health professionals
participating in health research with high-
quality protocols and early access to new
intervention and prevention strategies”
‘Five year aims’, page 6
[1] ‘Best Research for Best Health’ DoH, January 2006
• Q/ What HLO do we have for quality?
• Q/ What HLO do we have to support non-
commercial interventional studies?
Increase the number of
participants recruited
into NIHR CRN
Portfolio studies
Increase the proportion
of studies in the NIHR
CRN Portfolio delivering
to recruitment
target to time
Increase the number of
commercial contract
studies delivered
through the NIHR CRN
Reduce the time taken
for eligible studies to
achieve set-up in the
NHS
Reduce the time taken to
recruit to recruit first
participant into NIHR
Portfolio studies
Increase NHS
participation in NIHR
CRN Portfolio studies
Increase the number of
participants recruited
into Dementia and
Neurodegeneration
studies on the Portfolio
What is QUALITY in Clinical Research?
Does not have to be a
perfect solution…
What is QUALITY in Clinical Research to Me
NIHR Interventional Studies (Highest Quality)
• Changing patient care. Greatest potential to quickly translate into practice
• Studies are resource heavy, larger team, longer visits, follow-up visits
• Hard slog (time & effort), some work goes unrecognised
NIHR Observational Studies (Quality)
• Observing patient care. Quickly change practice?
• Less resource heavy; often without follow-up
• Quick wins. Can deliver more with less
My proxy for Quality = Participants in interventional studies
Total research participants
What Prompted the Question?
• Promoting and recognising quality and interventional studies?
• Price of everything (VfM) but value of nothing (QfM?)
• Success based on numbers (Partnership Board, League Tables)
• Celebrate the quick and easy, but less so the hard and difficult
• Sense that money does not follow activity (CRN>LCRN>?>Trust)
• Studies set-up to run slowly in a LCRN, rather than fast across many
• Trust ‘Sleeper Studies’ to bump up recruitment
• Obsession on numbers permeating to all staff
Do any of the above put the interests of science
and patients at the fore?
Delivering More With Less
• Funding is going down (in real terms)
• Based on anecdotal observations
• Questions:
1. Has the pursuit of numbers (HLO1) had an
impact on the quality (% interventional) of
research?
2. Has the pursuit of HLO1 (£) and HLO3 (£)
impacted on non-commercial interventional
studies?
NIHR Portfolio Studies (2008-2016)
[4] Data was collected from NIHR’s ‘Open Data Platform’ (data cut 5th Jan 2017)
NIHR Portfolio Studies by Type (2008-2016)
[4] Data was collected from NIHR’s ‘Open Data Platform’ (data cut 5th Jan 2017)
Non-Commercial Interventional Studies
• Q/Should we be concerned by 26% shift in Interventional
trials from non-commercial to commercial?
• Maybe so?
– Stepping stone for researchers (obs.>int.>commercial)
– Charity, University, NHS & NIHR sponsored
– What the UK is known for
– Not profit led, often looks at using existing medicines in new
combinations, conditions
• Maybe not?
– Is it not a consequence of commercial interventional doing so well?
– Actual number of non-commercial interventional is still increasing
NIHR Portfolio Recruitment (2008-2016)
NIHR Portfolio Recruitment by Type (2008-2016)
% Participants in Interventional Trials (2015/16)
[4] Data was collected from NIHR’s ‘Open Data Platform’ (data cut 5th Jan 2017)
Research at Typical Acute Trust
• Treats 731,114 patients p.a.
• 2,865 participate in research
• 117 studies
– Interventional ~40%
– Observational ~40%
– Commercial ~20%
Most Typical Trust:-
South Tees Hospitals NHS
Foundation Trust
% Participants in Interventional Trials (2015/16)
Top
Recruiting
DGH
Top
Recruiting
NHS Trust
[4] Data was collected from NIHR’s ‘Open Data Platform’ (data cut 5th Jan 2017)
Highest Quality
NHS Trust
(91st for recruits)
Is High Recruitment linked to Low Interventional Studies?
[4] Data was collected from NIHR’s ‘Open Data Platform’ (data cut 5th Jan 2017)
Quality & Quantity – Acute NHS Trusts 2015/16
Higher Quality
Higher Quantity
Higher Quality
Lower Quantity
Lower Quality
Higher Quantity
[5 Data was collected from NIHR’s ‘Open Data Platform’ (data cut 5th Jan 2017)
[5,6,7,8] Total patients treated (inpatient, outpatient, emergency & maternity)
Trust ‘Quality & Quantity’ Prescription
Q/ How can my local hospital go from
‘Lower Quality, Lower Quantity’ to ‘Higher
Quality, Higher Quantity’?
Currently 127 studies, 1,635 recruits
Require 70 Int. recruits pcm
[4] Data was collected from NIHR’s ‘Open Data Platform’ (data cut 5th Jan 2017)
[5,6,7,8] Total patients treated (inpatient, outpatient, emergency & maternity)
Quality* x Quantity* = Embedded Research Culture?
[5 Data was collected from NIHR’s ‘Open Data Platform’ (data cut 5th Jan 2017)
[5,6,7,8] Total patients treated (inpatient, outpatient, emergency & maternity)
* Need to ensure
Quality and Quantity
are equally weighted
NIHR Research Activity League Table [9]
• Published each year (2016/17 due soon!)
• Every NHS Trust taking part in research
• Currently recognises ‘participants’ & ‘studies’
• Celebrates performance at largest Trusts?
• Is it motivating to all Trusts?
• Used as a basis to make statements about
‘research culture’!
• Simple areas to make table more informative
Quality of Research = Interventional Participants / Total Participants
Quantity of Research = Research Participants / Total Patients Treated
• Multiply Quality by Culture then rank for ‘Embedded Research Culture’
Alternative–Research Activity League Table for 2015/2016
NHS Trust
(Acute)
Number of
Studies
Recruiting
Participants in
Studies
Relative
Quality1 of
Research
Relative
Quantity2 of
Research
Embedded
Research
Culture3
National Trust
Ranking
BIRMINGHAM WOMEN'S NHS FT 59 4,536 60.6% 2.6% 75.2% 1
GUY'S AND ST THOMAS' NHS FT 515 28,407 45.1% 1.8% 39.0% 2
UNIVERSITY HOSPITAL SOUTHAMPTON NHS FT 401 21,051 20.9% 2.4% 23.6% 3
ROYAL LIVERPOOL AND BROADGREEN UNI. HOSP. 161 8,866 44.7% 0.9% 18.6% 4
IMPERIAL COLLEGE HEALTHCARE NHS TRUST 437 13,973 29.6% 1.0% 13.7% 5
NORTH BRISTOL NHS TRUST 164 4,022 45.4% 0.6% 13.3% 6
SOUTH TYNESIDE NHS FT 35 953 80.6% 0.3% 11.9% 7
OXFORD UNIVERSITY HOSPITALS NHS FT 479 21,444 15.3% 1.6% 11.5% 8
THE ROYAL MARSDEN NHS FT 212 2,890 28.9% 0.8% 10.7% 9
BARTS HEALTH NHS TRUST 348 14,264 29.0% 0.7% 10.1% 10
THE WALTON CENTRE NHS FT 45 1,524 17.4% 1.2% 10.1% 11
MID ESSEX HOSPITAL SERVICES NHS TRUST 67 1,118 56.5% 0.4% 9.4% 12
HEART OF ENGLAND NHS RT 169 6,022 46.8% 0.4% 9.0% 13
SHEFFIELD TEACHING HOSPITALS NHS FT 378 8,799 34.2% 0.6% 8.9% 14
LIVERPOOL WOMEN'S NHS FT 42 1,336 35.0% 0.5% 8.8% 15
PORTSMOUTH HOSPITALS NHS TRUST 178 3,768 42.6% 0.4% 8.2% 16
PAPWORTH HOSPITAL NHS FT 54 1,138 16.4% 1.0% 8.1% 17
LEEDS TEACHING HOSPITALS NHS TRUST 491 11,893 24.0% 0.7% 8.1% 18
GREAT ORMOND STREET HOSPITAL FOR CHILDREN 176 3,926 11.8% 1.4% 7.8% 19
UNIVERSITY COLLEGE LONDON HOSPITALS NHS FT 410 10,473 25.3% 0.7% 7.7% 20
“Recognising NHS acute Trusts (regardless of size) for embedding a
research culture based on the number of their patients recruited into
research studies and the quality of the research studies they support”
Alternative LCRN Research League Table (Acute 2015/2016)
“Recognising LCRNs for embedding a research culture based on the
number of Trust patients recruited into research studies and the
quality of the research studies they support”
Local Research Network
(Acute NHS Trusts)
Number of
Studies
Recruiting
Participants in
Studies
Relative Quality1
of Research
Relative
Quantity2 of
Research
Embedded
Research
Culture3
National LCRN
Ranking4
South London 1,152 62,145 28.4% 0.55% 7.4 1 (2)
Wessex 821 42,883 23.5% 0.59% 6.6 2 (4)
North East and North Cumbria 851 33,961 39.9% 0.32% 6.0 3 (8)
North West Coast 742 28,787 28.0% 0.44% 5.9 4 (8)
North West London 770 27,765 26.8% 0.45% 5.7 5 (8)
Thames Valley and South Midlands 724 46,853 12.7% 0.82% 5.0 6 (1)
West Midlands 1,059 57,272 27.4% 0.38% 4.9 7 (3)
North Thames 1,386 74,064 30.0% 0.34% 4.8 8 (7)
West of England 646 26,772 31.8% 0.32% 4.8 9 (5)
East Midlands 868 42,823 31.2% 0.26% 3.9 10 (3)
South West Peninsula 587 24,670 25.3% 0.31% 3.7 11 (4)
Yorkshire and Humber 1,134 73,814 22.3% 0.33% 3.5 12 (10)
Eastern 855 37,580 22.6% 0.32% 3.4 13 (3)
Greater Manchester 986 40,126 17.5% 0.31% 2.5 14 (6)
Kent, Surrey and Sussex 639 35,215 27.8% 0.18% 2.4 15 (5)
Summing up – Working Better Together
• HLOs have been a success in getting us to where we are
• Indirectly, HLOs are now becoming counterproductive:
– Trusts having to do more with less resources
– Consciously/subconsciously prioritising quantity, as this is
what gets recognised
• Time for a new HLO1 metric that rewards quality & recognises
‘embedded research culture’ independent of Trust size
HLO1
Increase the number of
participants recruited
into NIHR CRN
Portfolio studies
HLO1
Increase the research
culture within NHS:
Quality of research
supported and number
of patients participating
in research.
• Recommend changes to ‘Research Activity League Table’
– Quality of Research (ODP)
– Quantity of Research (ODP & NHS Digital)
– Rank by ‘Embedded Research Culture’
Thank You &
Safe Journey Home
References
1. ‘Best research for best health: a new national health research strategy.’ Policy Paper, Department of
Health, 25th January 2006
2. ‘NIHR Clinical Research Network: Impact and Value Assessment.’ KPMG LLG, Public Version,
September 2016.
3. ‘NIHR CRN High Level Objectives Year End Performance Report 2015/16.’ NIHR Clinical Research
Network, Public Version: Version 1, 13th June 2016.
4. NIHR ‘Open Data Platform’ (data cut 5th January 2017
5. ‘Hospital Outpatient Activity 2015-16 in English NHS hospitals’. NHS Digital, 1st December 2016.
6. ‘Admitted patient care activity 2015-16 in English NHS hospitals’. NHS Digital, 9th November 2016.
7. ‘Hospital Accident and Emergency Activity, 2015-16 in English hospitals’. NHS Digital, 10th January.
2017.
8. ‘Hospital Maternity Activity, 2015-16 in English hospitals’. NHS Digital, November 9th 2016.
9. ‘NIHR Research Activity League Table’ 2015/16’

More Related Content

What's hot

Home Telehealth Monitoring Outcome Assessment - Kings Fund
Home Telehealth Monitoring Outcome Assessment - Kings FundHome Telehealth Monitoring Outcome Assessment - Kings Fund
Home Telehealth Monitoring Outcome Assessment - Kings Fund
johnstamford
 
Optimising Risk-Based Screening: The Case of Diabetic Eye Disease
Optimising Risk-Based Screening: The Case of Diabetic Eye DiseaseOptimising Risk-Based Screening: The Case of Diabetic Eye Disease
Optimising Risk-Based Screening: The Case of Diabetic Eye Disease
Office of Health Economics
 
NHSE RightCare - Liz Lingard
NHSE RightCare - Liz LingardNHSE RightCare - Liz Lingard
NHSE RightCare - Liz Lingard
National Osteoporosis Society
 
Newpathw
NewpathwNewpathw
Comparing HTA Outcomes for Centrally Authorized Medicinal Products in Great B...
Comparing HTA Outcomes for Centrally Authorized Medicinal Products in Great B...Comparing HTA Outcomes for Centrally Authorized Medicinal Products in Great B...
Comparing HTA Outcomes for Centrally Authorized Medicinal Products in Great B...
Office of Health Economics
 
Ispor workshop value-based_assess_nice_kks_nov2014
Ispor workshop value-based_assess_nice_kks_nov2014Ispor workshop value-based_assess_nice_kks_nov2014
Ispor workshop value-based_assess_nice_kks_nov2014
Office of Health Economics
 
Adaptive pathways intro_ispor_second_plenary_nov14
Adaptive pathways intro_ispor_second_plenary_nov14Adaptive pathways intro_ispor_second_plenary_nov14
Adaptive pathways intro_ispor_second_plenary_nov14
Office of Health Economics
 
Developing and Paying for Gene Therapies: Can We Resolve the Conflicts? A Eur...
Developing and Paying for Gene Therapies: Can We Resolve the Conflicts? A Eur...Developing and Paying for Gene Therapies: Can We Resolve the Conflicts? A Eur...
Developing and Paying for Gene Therapies: Can We Resolve the Conflicts? A Eur...
Office of Health Economics
 
Establishing a Fair Price for an Orphan Drug by Mikel Berdud et al.
Establishing a Fair Price for an Orphan Drug by Mikel Berdud et al.Establishing a Fair Price for an Orphan Drug by Mikel Berdud et al.
Establishing a Fair Price for an Orphan Drug by Mikel Berdud et al.
Office of Health Economics
 
ScHARR Health Economics and Decision Sciencs (HEDS) Newsletter- Summer 2015
ScHARR Health Economics and Decision Sciencs (HEDS) Newsletter- Summer 2015ScHARR Health Economics and Decision Sciencs (HEDS) Newsletter- Summer 2015
ScHARR Health Economics and Decision Sciencs (HEDS) Newsletter- Summer 2015
ScHARR HEDS
 
Adapting and implementing EB-CPGs at KSUMC at the First EBM & CPGs Conference...
Adapting and implementing EB-CPGs at KSUMC at the First EBM & CPGs Conference...Adapting and implementing EB-CPGs at KSUMC at the First EBM & CPGs Conference...
Adapting and implementing EB-CPGs at KSUMC at the First EBM & CPGs Conference...
Yasser Sami Abdel Dayem Amer
 
Dr.esmatullah shafaq thesis research proposal 20190112
Dr.esmatullah shafaq thesis research proposal 20190112Dr.esmatullah shafaq thesis research proposal 20190112
Dr.esmatullah shafaq thesis research proposal 20190112
EsmatullahShafaq
 
Adaptation of evidence-based clinical practice guidelines: the 'Adapted ADAPT...
Adaptation of evidence-based clinical practice guidelines: the 'Adapted ADAPT...Adaptation of evidence-based clinical practice guidelines: the 'Adapted ADAPT...
Adaptation of evidence-based clinical practice guidelines: the 'Adapted ADAPT...
Yasser Sami Abdel Dayem Amer
 
Do EQ-5D-3L and EQ-5D-5L Capture the Same Changes in Quality of Life Over Tim...
Do EQ-5D-3L and EQ-5D-5L Capture the Same Changes in Quality of Life Over Tim...Do EQ-5D-3L and EQ-5D-5L Capture the Same Changes in Quality of Life Over Tim...
Do EQ-5D-3L and EQ-5D-5L Capture the Same Changes in Quality of Life Over Tim...
Office of Health Economics
 
Sports injury research
Sports injury researchSports injury research
Sports injury research
Eliseu Correa
 
The Value of Targeted Sequencing in Advanced Cancer: DCE to Elicit the Public...
The Value of Targeted Sequencing in Advanced Cancer: DCE to Elicit the Public...The Value of Targeted Sequencing in Advanced Cancer: DCE to Elicit the Public...
The Value of Targeted Sequencing in Advanced Cancer: DCE to Elicit the Public...
Office of Health Economics
 
Academic doctors' views of complementary and alternative medicine (CAM) and i...
Academic doctors' views of complementary and alternative medicine (CAM) and i...Academic doctors' views of complementary and alternative medicine (CAM) and i...
Academic doctors' views of complementary and alternative medicine (CAM) and i...
home
 
Establishing a Reasonable Price for an Orphan Drug
Establishing a Reasonable Price for an Orphan DrugEstablishing a Reasonable Price for an Orphan Drug
Establishing a Reasonable Price for an Orphan Drug
Office of Health Economics
 
Defining and assessing a delineation uncertainty margin for modern radiotherapy
Defining and assessing a delineation uncertainty margin for modern radiotherapyDefining and assessing a delineation uncertainty margin for modern radiotherapy
Defining and assessing a delineation uncertainty margin for modern radiotherapy
Cancer Institute NSW
 
the GRImP protocol
the GRImP protocolthe GRImP protocol
the GRImP protocol
Kinda Ibrahim
 

What's hot (20)

Home Telehealth Monitoring Outcome Assessment - Kings Fund
Home Telehealth Monitoring Outcome Assessment - Kings FundHome Telehealth Monitoring Outcome Assessment - Kings Fund
Home Telehealth Monitoring Outcome Assessment - Kings Fund
 
Optimising Risk-Based Screening: The Case of Diabetic Eye Disease
Optimising Risk-Based Screening: The Case of Diabetic Eye DiseaseOptimising Risk-Based Screening: The Case of Diabetic Eye Disease
Optimising Risk-Based Screening: The Case of Diabetic Eye Disease
 
NHSE RightCare - Liz Lingard
NHSE RightCare - Liz LingardNHSE RightCare - Liz Lingard
NHSE RightCare - Liz Lingard
 
Newpathw
NewpathwNewpathw
Newpathw
 
Comparing HTA Outcomes for Centrally Authorized Medicinal Products in Great B...
Comparing HTA Outcomes for Centrally Authorized Medicinal Products in Great B...Comparing HTA Outcomes for Centrally Authorized Medicinal Products in Great B...
Comparing HTA Outcomes for Centrally Authorized Medicinal Products in Great B...
 
Ispor workshop value-based_assess_nice_kks_nov2014
Ispor workshop value-based_assess_nice_kks_nov2014Ispor workshop value-based_assess_nice_kks_nov2014
Ispor workshop value-based_assess_nice_kks_nov2014
 
Adaptive pathways intro_ispor_second_plenary_nov14
Adaptive pathways intro_ispor_second_plenary_nov14Adaptive pathways intro_ispor_second_plenary_nov14
Adaptive pathways intro_ispor_second_plenary_nov14
 
Developing and Paying for Gene Therapies: Can We Resolve the Conflicts? A Eur...
Developing and Paying for Gene Therapies: Can We Resolve the Conflicts? A Eur...Developing and Paying for Gene Therapies: Can We Resolve the Conflicts? A Eur...
Developing and Paying for Gene Therapies: Can We Resolve the Conflicts? A Eur...
 
Establishing a Fair Price for an Orphan Drug by Mikel Berdud et al.
Establishing a Fair Price for an Orphan Drug by Mikel Berdud et al.Establishing a Fair Price for an Orphan Drug by Mikel Berdud et al.
Establishing a Fair Price for an Orphan Drug by Mikel Berdud et al.
 
ScHARR Health Economics and Decision Sciencs (HEDS) Newsletter- Summer 2015
ScHARR Health Economics and Decision Sciencs (HEDS) Newsletter- Summer 2015ScHARR Health Economics and Decision Sciencs (HEDS) Newsletter- Summer 2015
ScHARR Health Economics and Decision Sciencs (HEDS) Newsletter- Summer 2015
 
Adapting and implementing EB-CPGs at KSUMC at the First EBM & CPGs Conference...
Adapting and implementing EB-CPGs at KSUMC at the First EBM & CPGs Conference...Adapting and implementing EB-CPGs at KSUMC at the First EBM & CPGs Conference...
Adapting and implementing EB-CPGs at KSUMC at the First EBM & CPGs Conference...
 
Dr.esmatullah shafaq thesis research proposal 20190112
Dr.esmatullah shafaq thesis research proposal 20190112Dr.esmatullah shafaq thesis research proposal 20190112
Dr.esmatullah shafaq thesis research proposal 20190112
 
Adaptation of evidence-based clinical practice guidelines: the 'Adapted ADAPT...
Adaptation of evidence-based clinical practice guidelines: the 'Adapted ADAPT...Adaptation of evidence-based clinical practice guidelines: the 'Adapted ADAPT...
Adaptation of evidence-based clinical practice guidelines: the 'Adapted ADAPT...
 
Do EQ-5D-3L and EQ-5D-5L Capture the Same Changes in Quality of Life Over Tim...
Do EQ-5D-3L and EQ-5D-5L Capture the Same Changes in Quality of Life Over Tim...Do EQ-5D-3L and EQ-5D-5L Capture the Same Changes in Quality of Life Over Tim...
Do EQ-5D-3L and EQ-5D-5L Capture the Same Changes in Quality of Life Over Tim...
 
Sports injury research
Sports injury researchSports injury research
Sports injury research
 
The Value of Targeted Sequencing in Advanced Cancer: DCE to Elicit the Public...
The Value of Targeted Sequencing in Advanced Cancer: DCE to Elicit the Public...The Value of Targeted Sequencing in Advanced Cancer: DCE to Elicit the Public...
The Value of Targeted Sequencing in Advanced Cancer: DCE to Elicit the Public...
 
Academic doctors' views of complementary and alternative medicine (CAM) and i...
Academic doctors' views of complementary and alternative medicine (CAM) and i...Academic doctors' views of complementary and alternative medicine (CAM) and i...
Academic doctors' views of complementary and alternative medicine (CAM) and i...
 
Establishing a Reasonable Price for an Orphan Drug
Establishing a Reasonable Price for an Orphan DrugEstablishing a Reasonable Price for an Orphan Drug
Establishing a Reasonable Price for an Orphan Drug
 
Defining and assessing a delineation uncertainty margin for modern radiotherapy
Defining and assessing a delineation uncertainty margin for modern radiotherapyDefining and assessing a delineation uncertainty margin for modern radiotherapy
Defining and assessing a delineation uncertainty margin for modern radiotherapy
 
the GRImP protocol
the GRImP protocolthe GRImP protocol
the GRImP protocol
 

Similar to An Alternative Clinical Research Activity League Table for Acute NHS Trusts and Local NIHR Clinical Research Networks...Time to Recognise Quality & Quantity

Dr Nicola Armstrong - Funding Opportunity for Public Health Research/Practice
Dr Nicola Armstrong - Funding Opportunity for Public Health Research/PracticeDr Nicola Armstrong - Funding Opportunity for Public Health Research/Practice
Dr Nicola Armstrong - Funding Opportunity for Public Health Research/Practice
Institute of Public Health in Ireland
 
Implementing Patient & Public Involvement in Research: 27.06.2017
Implementing Patient & Public Involvement in Research: 27.06.2017Implementing Patient & Public Involvement in Research: 27.06.2017
Implementing Patient & Public Involvement in Research: 27.06.2017
RDSLondon
 
NIHR Research Design Service
NIHR Research Design ServiceNIHR Research Design Service
NIHR Research Design Service
Azeem Majeed
 
Let's Talk Research Annual Conference - 24th-25th September 2014 (Dr Sally Gi...
Let's Talk Research Annual Conference - 24th-25th September 2014 (Dr Sally Gi...Let's Talk Research Annual Conference - 24th-25th September 2014 (Dr Sally Gi...
Let's Talk Research Annual Conference - 24th-25th September 2014 (Dr Sally Gi...
NHSNWRD
 
Caroline Watkins
Caroline Watkins Caroline Watkins
Caroline Watkins
NHSNWRD
 
North West London Research Symposium for health professions 2015
North West London Research Symposium for health professions 2015North West London Research Symposium for health professions 2015
North West London Research Symposium for health professions 2015
Professor Priscilla Harries
 
William van't Hoff - How to embed research in NHS trusts to improve patient care
William van't Hoff - How to embed research in NHS trusts to improve patient careWilliam van't Hoff - How to embed research in NHS trusts to improve patient care
William van't Hoff - How to embed research in NHS trusts to improve patient care
Innovation Agency
 
Driving progress in healthcare through NHS research
Driving progress in healthcare through NHS researchDriving progress in healthcare through NHS research
Driving progress in healthcare through NHS research
Health and Care Innovation Expo
 
Mairead O'Driscoll, PhD Director, Research Strategy and Funding Directorate, ...
Mairead O'Driscoll, PhD Director, Research Strategy and Funding Directorate, ...Mairead O'Driscoll, PhD Director, Research Strategy and Funding Directorate, ...
Mairead O'Driscoll, PhD Director, Research Strategy and Funding Directorate, ...
Investnet
 
Presentation to National Institute for Health Research (NIHR) Public Involvem...
Presentation to National Institute for Health Research (NIHR) Public Involvem...Presentation to National Institute for Health Research (NIHR) Public Involvem...
Presentation to National Institute for Health Research (NIHR) Public Involvem...
Simon Denegri
 
Strategic development of patient and public involvement in a major comparativ...
Strategic development of patient and public involvement in a major comparativ...Strategic development of patient and public involvement in a major comparativ...
Strategic development of patient and public involvement in a major comparativ...
HTAi Bilbao 2012
 
Growing the health and wealth of the nation through research, pop up uni, 11a...
Growing the health and wealth of the nation through research, pop up uni, 11a...Growing the health and wealth of the nation through research, pop up uni, 11a...
Growing the health and wealth of the nation through research, pop up uni, 11a...
NHS England
 
Dr. Martin Bardsley Digital Health Assembly 2015
Dr. Martin Bardsley Digital Health Assembly 2015Dr. Martin Bardsley Digital Health Assembly 2015
Dr. Martin Bardsley Digital Health Assembly 2015
DHA2015
 
The 45 and Up Study Update
The 45 and Up Study UpdateThe 45 and Up Study Update
The 45 and Up Study Update
Sax Institute
 
B Moore Presentation 07 01 09
B Moore Presentation 07 01 09B Moore Presentation 07 01 09
B Moore Presentation 07 01 09
Pierre Trudelle
 
Nhs innovation accelerator understanding how and why the nhs adopts innovation
Nhs innovation accelerator   understanding how and why the nhs adopts innovationNhs innovation accelerator   understanding how and why the nhs adopts innovation
Nhs innovation accelerator understanding how and why the nhs adopts innovation
Hugh Risebrow
 
Improving Care: More Method, Less Uncertainty, Impact summit 30 October 2013
Improving Care: More Method, Less Uncertainty, Impact summit 30 October 2013Improving Care: More Method, Less Uncertainty, Impact summit 30 October 2013
Improving Care: More Method, Less Uncertainty, Impact summit 30 October 2013
NHS Improving Quality
 
Alberta 2015
Alberta 2015Alberta 2015
Alberta 2015
Simon Denegri
 
NIHR CLAHRC East Midlands Annual Meeting 2015 presentations - Day 2
NIHR CLAHRC East Midlands Annual Meeting 2015 presentations - Day 2NIHR CLAHRC East Midlands Annual Meeting 2015 presentations - Day 2
NIHR CLAHRC East Midlands Annual Meeting 2015 presentations - Day 2
CLAHRC-NDL
 
Let's Talk Research Annual Conference - 24th-25th September 2014 (Simon Denegri)
Let's Talk Research Annual Conference - 24th-25th September 2014 (Simon Denegri)Let's Talk Research Annual Conference - 24th-25th September 2014 (Simon Denegri)
Let's Talk Research Annual Conference - 24th-25th September 2014 (Simon Denegri)
NHSNWRD
 

Similar to An Alternative Clinical Research Activity League Table for Acute NHS Trusts and Local NIHR Clinical Research Networks...Time to Recognise Quality & Quantity (20)

Dr Nicola Armstrong - Funding Opportunity for Public Health Research/Practice
Dr Nicola Armstrong - Funding Opportunity for Public Health Research/PracticeDr Nicola Armstrong - Funding Opportunity for Public Health Research/Practice
Dr Nicola Armstrong - Funding Opportunity for Public Health Research/Practice
 
Implementing Patient & Public Involvement in Research: 27.06.2017
Implementing Patient & Public Involvement in Research: 27.06.2017Implementing Patient & Public Involvement in Research: 27.06.2017
Implementing Patient & Public Involvement in Research: 27.06.2017
 
NIHR Research Design Service
NIHR Research Design ServiceNIHR Research Design Service
NIHR Research Design Service
 
Let's Talk Research Annual Conference - 24th-25th September 2014 (Dr Sally Gi...
Let's Talk Research Annual Conference - 24th-25th September 2014 (Dr Sally Gi...Let's Talk Research Annual Conference - 24th-25th September 2014 (Dr Sally Gi...
Let's Talk Research Annual Conference - 24th-25th September 2014 (Dr Sally Gi...
 
Caroline Watkins
Caroline Watkins Caroline Watkins
Caroline Watkins
 
North West London Research Symposium for health professions 2015
North West London Research Symposium for health professions 2015North West London Research Symposium for health professions 2015
North West London Research Symposium for health professions 2015
 
William van't Hoff - How to embed research in NHS trusts to improve patient care
William van't Hoff - How to embed research in NHS trusts to improve patient careWilliam van't Hoff - How to embed research in NHS trusts to improve patient care
William van't Hoff - How to embed research in NHS trusts to improve patient care
 
Driving progress in healthcare through NHS research
Driving progress in healthcare through NHS researchDriving progress in healthcare through NHS research
Driving progress in healthcare through NHS research
 
Mairead O'Driscoll, PhD Director, Research Strategy and Funding Directorate, ...
Mairead O'Driscoll, PhD Director, Research Strategy and Funding Directorate, ...Mairead O'Driscoll, PhD Director, Research Strategy and Funding Directorate, ...
Mairead O'Driscoll, PhD Director, Research Strategy and Funding Directorate, ...
 
Presentation to National Institute for Health Research (NIHR) Public Involvem...
Presentation to National Institute for Health Research (NIHR) Public Involvem...Presentation to National Institute for Health Research (NIHR) Public Involvem...
Presentation to National Institute for Health Research (NIHR) Public Involvem...
 
Strategic development of patient and public involvement in a major comparativ...
Strategic development of patient and public involvement in a major comparativ...Strategic development of patient and public involvement in a major comparativ...
Strategic development of patient and public involvement in a major comparativ...
 
Growing the health and wealth of the nation through research, pop up uni, 11a...
Growing the health and wealth of the nation through research, pop up uni, 11a...Growing the health and wealth of the nation through research, pop up uni, 11a...
Growing the health and wealth of the nation through research, pop up uni, 11a...
 
Dr. Martin Bardsley Digital Health Assembly 2015
Dr. Martin Bardsley Digital Health Assembly 2015Dr. Martin Bardsley Digital Health Assembly 2015
Dr. Martin Bardsley Digital Health Assembly 2015
 
The 45 and Up Study Update
The 45 and Up Study UpdateThe 45 and Up Study Update
The 45 and Up Study Update
 
B Moore Presentation 07 01 09
B Moore Presentation 07 01 09B Moore Presentation 07 01 09
B Moore Presentation 07 01 09
 
Nhs innovation accelerator understanding how and why the nhs adopts innovation
Nhs innovation accelerator   understanding how and why the nhs adopts innovationNhs innovation accelerator   understanding how and why the nhs adopts innovation
Nhs innovation accelerator understanding how and why the nhs adopts innovation
 
Improving Care: More Method, Less Uncertainty, Impact summit 30 October 2013
Improving Care: More Method, Less Uncertainty, Impact summit 30 October 2013Improving Care: More Method, Less Uncertainty, Impact summit 30 October 2013
Improving Care: More Method, Less Uncertainty, Impact summit 30 October 2013
 
Alberta 2015
Alberta 2015Alberta 2015
Alberta 2015
 
NIHR CLAHRC East Midlands Annual Meeting 2015 presentations - Day 2
NIHR CLAHRC East Midlands Annual Meeting 2015 presentations - Day 2NIHR CLAHRC East Midlands Annual Meeting 2015 presentations - Day 2
NIHR CLAHRC East Midlands Annual Meeting 2015 presentations - Day 2
 
Let's Talk Research Annual Conference - 24th-25th September 2014 (Simon Denegri)
Let's Talk Research Annual Conference - 24th-25th September 2014 (Simon Denegri)Let's Talk Research Annual Conference - 24th-25th September 2014 (Simon Denegri)
Let's Talk Research Annual Conference - 24th-25th September 2014 (Simon Denegri)
 

More from Paul Roberts

'Research Focus' MEHT Summer R&D Newsletter 2018
'Research Focus' MEHT Summer R&D Newsletter 2018'Research Focus' MEHT Summer R&D Newsletter 2018
'Research Focus' MEHT Summer R&D Newsletter 2018
Paul Roberts
 
Research focus issue6_spring 2018
Research focus issue6_spring 2018Research focus issue6_spring 2018
Research focus issue6_spring 2018
Paul Roberts
 
'Research Focus' - Winter Newsletter from the R&D Department at Broomfield Ho...
'Research Focus' - Winter Newsletter from the R&D Department at Broomfield Ho...'Research Focus' - Winter Newsletter from the R&D Department at Broomfield Ho...
'Research Focus' - Winter Newsletter from the R&D Department at Broomfield Ho...
Paul Roberts
 
Broomfield Hospital Research Publications During 2017
Broomfield Hospital Research Publications During 2017Broomfield Hospital Research Publications During 2017
Broomfield Hospital Research Publications During 2017
Paul Roberts
 
Research Focus - Q3 201718 Autumn R&D Newsletter
Research Focus - Q3 201718 Autumn R&D NewsletterResearch Focus - Q3 201718 Autumn R&D Newsletter
Research Focus - Q3 201718 Autumn R&D Newsletter
Paul Roberts
 
Research Focus edition3_summer_201718
Research Focus edition3_summer_201718Research Focus edition3_summer_201718
Research Focus edition3_summer_201718
Paul Roberts
 

More from Paul Roberts (6)

'Research Focus' MEHT Summer R&D Newsletter 2018
'Research Focus' MEHT Summer R&D Newsletter 2018'Research Focus' MEHT Summer R&D Newsletter 2018
'Research Focus' MEHT Summer R&D Newsletter 2018
 
Research focus issue6_spring 2018
Research focus issue6_spring 2018Research focus issue6_spring 2018
Research focus issue6_spring 2018
 
'Research Focus' - Winter Newsletter from the R&D Department at Broomfield Ho...
'Research Focus' - Winter Newsletter from the R&D Department at Broomfield Ho...'Research Focus' - Winter Newsletter from the R&D Department at Broomfield Ho...
'Research Focus' - Winter Newsletter from the R&D Department at Broomfield Ho...
 
Broomfield Hospital Research Publications During 2017
Broomfield Hospital Research Publications During 2017Broomfield Hospital Research Publications During 2017
Broomfield Hospital Research Publications During 2017
 
Research Focus - Q3 201718 Autumn R&D Newsletter
Research Focus - Q3 201718 Autumn R&D NewsletterResearch Focus - Q3 201718 Autumn R&D Newsletter
Research Focus - Q3 201718 Autumn R&D Newsletter
 
Research Focus edition3_summer_201718
Research Focus edition3_summer_201718Research Focus edition3_summer_201718
Research Focus edition3_summer_201718
 

Recently uploaded

10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations   10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations
Traumasoft LLC
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
Josep Vidal-Alaball
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
suvadeepdas911
 
Cervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptxCervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptx
LEFLOT Jean-Louis
 
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
MedicoseAcademics
 
LOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIES
LOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIESLOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIES
LOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIES
ShraddhaTamshettiwar
 
vonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentationvonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentation
Dr.pavithra Anandan
 
Pollen and Fungal allergy: aeroallergy.pdf
Pollen and Fungal allergy: aeroallergy.pdfPollen and Fungal allergy: aeroallergy.pdf
Pollen and Fungal allergy: aeroallergy.pdf
Chulalongkorn Allergy and Clinical Immunology Research Group
 
Tele Optometry (kunj'sppt) / Basics of tele optometry.
Tele Optometry (kunj'sppt) / Basics of tele optometry.Tele Optometry (kunj'sppt) / Basics of tele optometry.
Tele Optometry (kunj'sppt) / Basics of tele optometry.
Kunj Vihari
 
Nano-gold for Cancer Therapy chemistry investigatory project
Nano-gold for Cancer Therapy chemistry investigatory projectNano-gold for Cancer Therapy chemistry investigatory project
Nano-gold for Cancer Therapy chemistry investigatory project
SIVAVINAYAKPK
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
rishi2789
 
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptxCLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
Government Dental College & Hospital Srinagar
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
rishi2789
 
Skin Diseases That Happen During Summer.
 Skin Diseases That Happen During Summer. Skin Diseases That Happen During Summer.
Skin Diseases That Happen During Summer.
Gokuldas Hospital
 
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Kosmoderma Academy Of Aesthetic Medicine
 
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdfMedical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Jim Jacob Roy
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 
Acute Gout Care & Urate Lowering Therapy .pdf
Acute Gout Care & Urate Lowering Therapy .pdfAcute Gout Care & Urate Lowering Therapy .pdf
Acute Gout Care & Urate Lowering Therapy .pdf
Jim Jacob Roy
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
rishi2789
 

Recently uploaded (20)

10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations   10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
 
Cervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptxCervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptx
 
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
 
LOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIES
LOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIESLOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIES
LOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIES
 
vonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentationvonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentation
 
Pollen and Fungal allergy: aeroallergy.pdf
Pollen and Fungal allergy: aeroallergy.pdfPollen and Fungal allergy: aeroallergy.pdf
Pollen and Fungal allergy: aeroallergy.pdf
 
Tele Optometry (kunj'sppt) / Basics of tele optometry.
Tele Optometry (kunj'sppt) / Basics of tele optometry.Tele Optometry (kunj'sppt) / Basics of tele optometry.
Tele Optometry (kunj'sppt) / Basics of tele optometry.
 
Nano-gold for Cancer Therapy chemistry investigatory project
Nano-gold for Cancer Therapy chemistry investigatory projectNano-gold for Cancer Therapy chemistry investigatory project
Nano-gold for Cancer Therapy chemistry investigatory project
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
 
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptxCLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
 
Skin Diseases That Happen During Summer.
 Skin Diseases That Happen During Summer. Skin Diseases That Happen During Summer.
Skin Diseases That Happen During Summer.
 
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
 
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdfMedical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 
Acute Gout Care & Urate Lowering Therapy .pdf
Acute Gout Care & Urate Lowering Therapy .pdfAcute Gout Care & Urate Lowering Therapy .pdf
Acute Gout Care & Urate Lowering Therapy .pdf
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
 

An Alternative Clinical Research Activity League Table for Acute NHS Trusts and Local NIHR Clinical Research Networks...Time to Recognise Quality & Quantity

  • 1. Is there any evidence that ‘NIHR HLO1’ has had a counterproductive impact upon the intrinsic quality of research being delivered through the NHS in England between 2008 & 2016? Discussion Session – Theme 3 ‘Working Better Together’
  • 2.
  • 3. Today’s Session 1. Background 2. What prompted the question? 3. What does the data look like? 4. Delivering quality & quantity 5. Working better together 6. What’s been left unsaid
  • 4. NIHR Clinical Research Network • [1] Set up in 2006 to “Improve health and wealth of nation” • 15 LCRNs, Central Coordinating Centre • All NHS Trusts research active • ~650,000 participants, ~4,500 studies p.a. • UK more attractive to Sponsors • Retained & increased commercial research activity • Research training (~100,000 GCP) • Fund a large workforce (~40,000 staff) • [2] Economic and health benefits (KPMG LLG, 2016) Key to success, several key performance indicators [3]…
  • 5. Increase the number of participants recruited into NIHR CRN Portfolio studies Increase the proportion of studies in the NIHR CRN Portfolio delivering to recruitment target to time Increase the number of commercial contract studies delivered through the NIHR CRN Reduce the time taken for eligible studies to achieve set-up in the NHS Reduce the time taken to recruit to recruit first participant into NIHR Portfolio studies Increase NHS participation in NIHR CRN Portfolio studies Increase the number of participants recruited into Dementia and Neurodegeneration studies on the Portfolio
  • 6. NIHR CRN – Founding Aims “More patients and health professionals participating in health research with high- quality protocols and early access to new intervention and prevention strategies” ‘Five year aims’, page 6 [1] ‘Best Research for Best Health’ DoH, January 2006 • Q/ What HLO do we have for quality? • Q/ What HLO do we have to support non- commercial interventional studies?
  • 7. Increase the number of participants recruited into NIHR CRN Portfolio studies Increase the proportion of studies in the NIHR CRN Portfolio delivering to recruitment target to time Increase the number of commercial contract studies delivered through the NIHR CRN Reduce the time taken for eligible studies to achieve set-up in the NHS Reduce the time taken to recruit to recruit first participant into NIHR Portfolio studies Increase NHS participation in NIHR CRN Portfolio studies Increase the number of participants recruited into Dementia and Neurodegeneration studies on the Portfolio
  • 8. What is QUALITY in Clinical Research? Does not have to be a perfect solution…
  • 9. What is QUALITY in Clinical Research to Me NIHR Interventional Studies (Highest Quality) • Changing patient care. Greatest potential to quickly translate into practice • Studies are resource heavy, larger team, longer visits, follow-up visits • Hard slog (time & effort), some work goes unrecognised NIHR Observational Studies (Quality) • Observing patient care. Quickly change practice? • Less resource heavy; often without follow-up • Quick wins. Can deliver more with less My proxy for Quality = Participants in interventional studies Total research participants
  • 10. What Prompted the Question? • Promoting and recognising quality and interventional studies? • Price of everything (VfM) but value of nothing (QfM?) • Success based on numbers (Partnership Board, League Tables) • Celebrate the quick and easy, but less so the hard and difficult • Sense that money does not follow activity (CRN>LCRN>?>Trust) • Studies set-up to run slowly in a LCRN, rather than fast across many • Trust ‘Sleeper Studies’ to bump up recruitment • Obsession on numbers permeating to all staff Do any of the above put the interests of science and patients at the fore?
  • 11. Delivering More With Less • Funding is going down (in real terms) • Based on anecdotal observations • Questions: 1. Has the pursuit of numbers (HLO1) had an impact on the quality (% interventional) of research? 2. Has the pursuit of HLO1 (£) and HLO3 (£) impacted on non-commercial interventional studies?
  • 12. NIHR Portfolio Studies (2008-2016) [4] Data was collected from NIHR’s ‘Open Data Platform’ (data cut 5th Jan 2017)
  • 13. NIHR Portfolio Studies by Type (2008-2016) [4] Data was collected from NIHR’s ‘Open Data Platform’ (data cut 5th Jan 2017)
  • 14. Non-Commercial Interventional Studies • Q/Should we be concerned by 26% shift in Interventional trials from non-commercial to commercial? • Maybe so? – Stepping stone for researchers (obs.>int.>commercial) – Charity, University, NHS & NIHR sponsored – What the UK is known for – Not profit led, often looks at using existing medicines in new combinations, conditions • Maybe not? – Is it not a consequence of commercial interventional doing so well? – Actual number of non-commercial interventional is still increasing
  • 16. NIHR Portfolio Recruitment by Type (2008-2016)
  • 17.
  • 18. % Participants in Interventional Trials (2015/16) [4] Data was collected from NIHR’s ‘Open Data Platform’ (data cut 5th Jan 2017)
  • 19. Research at Typical Acute Trust • Treats 731,114 patients p.a. • 2,865 participate in research • 117 studies – Interventional ~40% – Observational ~40% – Commercial ~20% Most Typical Trust:- South Tees Hospitals NHS Foundation Trust
  • 20. % Participants in Interventional Trials (2015/16) Top Recruiting DGH Top Recruiting NHS Trust [4] Data was collected from NIHR’s ‘Open Data Platform’ (data cut 5th Jan 2017) Highest Quality NHS Trust (91st for recruits)
  • 21. Is High Recruitment linked to Low Interventional Studies? [4] Data was collected from NIHR’s ‘Open Data Platform’ (data cut 5th Jan 2017)
  • 22. Quality & Quantity – Acute NHS Trusts 2015/16 Higher Quality Higher Quantity Higher Quality Lower Quantity Lower Quality Higher Quantity [5 Data was collected from NIHR’s ‘Open Data Platform’ (data cut 5th Jan 2017) [5,6,7,8] Total patients treated (inpatient, outpatient, emergency & maternity)
  • 23. Trust ‘Quality & Quantity’ Prescription Q/ How can my local hospital go from ‘Lower Quality, Lower Quantity’ to ‘Higher Quality, Higher Quantity’? Currently 127 studies, 1,635 recruits Require 70 Int. recruits pcm [4] Data was collected from NIHR’s ‘Open Data Platform’ (data cut 5th Jan 2017) [5,6,7,8] Total patients treated (inpatient, outpatient, emergency & maternity)
  • 24. Quality* x Quantity* = Embedded Research Culture? [5 Data was collected from NIHR’s ‘Open Data Platform’ (data cut 5th Jan 2017) [5,6,7,8] Total patients treated (inpatient, outpatient, emergency & maternity) * Need to ensure Quality and Quantity are equally weighted
  • 25. NIHR Research Activity League Table [9] • Published each year (2016/17 due soon!) • Every NHS Trust taking part in research • Currently recognises ‘participants’ & ‘studies’ • Celebrates performance at largest Trusts? • Is it motivating to all Trusts? • Used as a basis to make statements about ‘research culture’! • Simple areas to make table more informative Quality of Research = Interventional Participants / Total Participants Quantity of Research = Research Participants / Total Patients Treated • Multiply Quality by Culture then rank for ‘Embedded Research Culture’
  • 26. Alternative–Research Activity League Table for 2015/2016 NHS Trust (Acute) Number of Studies Recruiting Participants in Studies Relative Quality1 of Research Relative Quantity2 of Research Embedded Research Culture3 National Trust Ranking BIRMINGHAM WOMEN'S NHS FT 59 4,536 60.6% 2.6% 75.2% 1 GUY'S AND ST THOMAS' NHS FT 515 28,407 45.1% 1.8% 39.0% 2 UNIVERSITY HOSPITAL SOUTHAMPTON NHS FT 401 21,051 20.9% 2.4% 23.6% 3 ROYAL LIVERPOOL AND BROADGREEN UNI. HOSP. 161 8,866 44.7% 0.9% 18.6% 4 IMPERIAL COLLEGE HEALTHCARE NHS TRUST 437 13,973 29.6% 1.0% 13.7% 5 NORTH BRISTOL NHS TRUST 164 4,022 45.4% 0.6% 13.3% 6 SOUTH TYNESIDE NHS FT 35 953 80.6% 0.3% 11.9% 7 OXFORD UNIVERSITY HOSPITALS NHS FT 479 21,444 15.3% 1.6% 11.5% 8 THE ROYAL MARSDEN NHS FT 212 2,890 28.9% 0.8% 10.7% 9 BARTS HEALTH NHS TRUST 348 14,264 29.0% 0.7% 10.1% 10 THE WALTON CENTRE NHS FT 45 1,524 17.4% 1.2% 10.1% 11 MID ESSEX HOSPITAL SERVICES NHS TRUST 67 1,118 56.5% 0.4% 9.4% 12 HEART OF ENGLAND NHS RT 169 6,022 46.8% 0.4% 9.0% 13 SHEFFIELD TEACHING HOSPITALS NHS FT 378 8,799 34.2% 0.6% 8.9% 14 LIVERPOOL WOMEN'S NHS FT 42 1,336 35.0% 0.5% 8.8% 15 PORTSMOUTH HOSPITALS NHS TRUST 178 3,768 42.6% 0.4% 8.2% 16 PAPWORTH HOSPITAL NHS FT 54 1,138 16.4% 1.0% 8.1% 17 LEEDS TEACHING HOSPITALS NHS TRUST 491 11,893 24.0% 0.7% 8.1% 18 GREAT ORMOND STREET HOSPITAL FOR CHILDREN 176 3,926 11.8% 1.4% 7.8% 19 UNIVERSITY COLLEGE LONDON HOSPITALS NHS FT 410 10,473 25.3% 0.7% 7.7% 20 “Recognising NHS acute Trusts (regardless of size) for embedding a research culture based on the number of their patients recruited into research studies and the quality of the research studies they support”
  • 27. Alternative LCRN Research League Table (Acute 2015/2016) “Recognising LCRNs for embedding a research culture based on the number of Trust patients recruited into research studies and the quality of the research studies they support” Local Research Network (Acute NHS Trusts) Number of Studies Recruiting Participants in Studies Relative Quality1 of Research Relative Quantity2 of Research Embedded Research Culture3 National LCRN Ranking4 South London 1,152 62,145 28.4% 0.55% 7.4 1 (2) Wessex 821 42,883 23.5% 0.59% 6.6 2 (4) North East and North Cumbria 851 33,961 39.9% 0.32% 6.0 3 (8) North West Coast 742 28,787 28.0% 0.44% 5.9 4 (8) North West London 770 27,765 26.8% 0.45% 5.7 5 (8) Thames Valley and South Midlands 724 46,853 12.7% 0.82% 5.0 6 (1) West Midlands 1,059 57,272 27.4% 0.38% 4.9 7 (3) North Thames 1,386 74,064 30.0% 0.34% 4.8 8 (7) West of England 646 26,772 31.8% 0.32% 4.8 9 (5) East Midlands 868 42,823 31.2% 0.26% 3.9 10 (3) South West Peninsula 587 24,670 25.3% 0.31% 3.7 11 (4) Yorkshire and Humber 1,134 73,814 22.3% 0.33% 3.5 12 (10) Eastern 855 37,580 22.6% 0.32% 3.4 13 (3) Greater Manchester 986 40,126 17.5% 0.31% 2.5 14 (6) Kent, Surrey and Sussex 639 35,215 27.8% 0.18% 2.4 15 (5)
  • 28. Summing up – Working Better Together • HLOs have been a success in getting us to where we are • Indirectly, HLOs are now becoming counterproductive: – Trusts having to do more with less resources – Consciously/subconsciously prioritising quantity, as this is what gets recognised • Time for a new HLO1 metric that rewards quality & recognises ‘embedded research culture’ independent of Trust size HLO1 Increase the number of participants recruited into NIHR CRN Portfolio studies HLO1 Increase the research culture within NHS: Quality of research supported and number of patients participating in research. • Recommend changes to ‘Research Activity League Table’ – Quality of Research (ODP) – Quantity of Research (ODP & NHS Digital) – Rank by ‘Embedded Research Culture’
  • 29. Thank You & Safe Journey Home
  • 30. References 1. ‘Best research for best health: a new national health research strategy.’ Policy Paper, Department of Health, 25th January 2006 2. ‘NIHR Clinical Research Network: Impact and Value Assessment.’ KPMG LLG, Public Version, September 2016. 3. ‘NIHR CRN High Level Objectives Year End Performance Report 2015/16.’ NIHR Clinical Research Network, Public Version: Version 1, 13th June 2016. 4. NIHR ‘Open Data Platform’ (data cut 5th January 2017 5. ‘Hospital Outpatient Activity 2015-16 in English NHS hospitals’. NHS Digital, 1st December 2016. 6. ‘Admitted patient care activity 2015-16 in English NHS hospitals’. NHS Digital, 9th November 2016. 7. ‘Hospital Accident and Emergency Activity, 2015-16 in English hospitals’. NHS Digital, 10th January. 2017. 8. ‘Hospital Maternity Activity, 2015-16 in English hospitals’. NHS Digital, November 9th 2016. 9. ‘NIHR Research Activity League Table’ 2015/16’